# Corneal Collagen Crosslinking for Progressive Keratoconus and Ectasia Using Riboflavin/Dextran and Hypotonic Riboflavin

> **NCT01152541** · PHASE3 · UNKNOWN · sponsor: **Cornea and Laser Eye Institute** · enrollment: 160 (estimated)

## Conditions studied

- Keratoconus
- Corneal Ectasia

## Interventions

- **DRUG:** Riboflavin/Dextran
- **DRUG:** Hypotonic Riboflavin

## Key facts

- **NCT ID:** NCT01152541
- **Lead sponsor:** Cornea and Laser Eye Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-06
- **Primary completion:** 2024-12
- **Final completion:** 2025-12
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01152541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01152541, "Corneal Collagen Crosslinking for Progressive Keratoconus and Ectasia Using Riboflavin/Dextran and Hypotonic Riboflavin". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01152541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*